Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 7/2005

01-08-2005 | Original Articles

Radioquimioterapia de la enfermedad limitada del carcinoma pulmonar de célula pequeña. ¿Tratamiento concomitante en protocolos asistenciales?

Authors: Ana Lucas Calduch, María Dolores Arnaiz Fernández, Sol San José Maderuelo, Valentí Navarro Pérez, Gala Serrano Bermúdez, Ana Montes Borinaga, Felipe Cardenal Alemany, Branislav Jeremic, Ferran Guedea Edo

Published in: Clinical and Translational Oncology | Issue 7/2005

Login to get access
Metadata
Title
Radioquimioterapia de la enfermedad limitada del carcinoma pulmonar de célula pequeña. ¿Tratamiento concomitante en protocolos asistenciales?
Authors
Ana Lucas Calduch
María Dolores Arnaiz Fernández
Sol San José Maderuelo
Valentí Navarro Pérez
Gala Serrano Bermúdez
Ana Montes Borinaga
Felipe Cardenal Alemany
Branislav Jeremic
Ferran Guedea Edo
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 7/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710271

Other articles of this Issue 7/2005

Clinical and Translational Oncology 7/2005 Go to the issue

Educational Review

Estado actual del diagnóstico y tratamiento del hepatoblastoma

Review

Dilemas al final de la vida

Editorial

El final de la última enfermedad

Special Article

Los cuidados de soporte en Oncología radioterápica

Case Reports

Epididymal metastases as the first sign of a colon cancer recurrence

Case Reports

Metastases in the sphenoidal sinus in a patient with papillary thyroid cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits